1. Home
  2. WST vs STM Comparison

WST vs STM Comparison

Compare WST & STM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • STM
  • Stock Information
  • Founded
  • WST 1923
  • STM 1987
  • Country
  • WST United States
  • STM Netherlands
  • Employees
  • WST N/A
  • STM N/A
  • Industry
  • WST Medical/Dental Instruments
  • STM Semiconductors
  • Sector
  • WST Health Care
  • STM Technology
  • Exchange
  • WST Nasdaq
  • STM Nasdaq
  • Market Cap
  • WST 15.6B
  • STM 22.3B
  • IPO Year
  • WST N/A
  • STM 1994
  • Fundamental
  • Price
  • WST $222.26
  • STM $32.26
  • Analyst Decision
  • WST Buy
  • STM Buy
  • Analyst Count
  • WST 7
  • STM 8
  • Target Price
  • WST $331.67
  • STM $32.00
  • AVG Volume (30 Days)
  • WST 686.1K
  • STM 7.2M
  • Earning Date
  • WST 07-24-2025
  • STM 07-24-2025
  • Dividend Yield
  • WST 0.38%
  • STM 0.99%
  • EPS Growth
  • WST N/A
  • STM N/A
  • EPS
  • WST 6.37
  • STM 1.18
  • Revenue
  • WST $2,895,800,000.00
  • STM $12,321,000,000.00
  • Revenue This Year
  • WST $3.38
  • STM N/A
  • Revenue Next Year
  • WST $5.85
  • STM $14.19
  • P/E Ratio
  • WST $34.87
  • STM $26.26
  • Revenue Growth
  • WST N/A
  • STM N/A
  • 52 Week Low
  • WST $187.43
  • STM $17.25
  • 52 Week High
  • WST $352.33
  • STM $43.32
  • Technical
  • Relative Strength Index (RSI)
  • WST 55.47
  • STM 72.64
  • Support Level
  • WST $215.67
  • STM $29.70
  • Resistance Level
  • WST $226.80
  • STM $30.59
  • Average True Range (ATR)
  • WST 5.26
  • STM 0.58
  • MACD
  • WST -0.04
  • STM 0.06
  • Stochastic Oscillator
  • WST 65.84
  • STM 96.14

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About STM STMicroelectronics N.V.

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.

Share on Social Networks: